Hafnia is a leader in refined product shipping with low P/E, high dividends, and strong cash flow. Read here for an analysis ...

President Donald Trump's announcement is the administration's latest move in its concerted effort to shift the people and ...

The 'Problem Child' and Alvarez have traded barbs in recent months after their rumoured fight was scrapped at the eleventh ...

Supervielle is transforming, with over 50% of its portfolio in consumer loans and 600,000+ active digital users. Click here to find out why SUPV stock is a Buy.

In the neoadjuvant and adjuvant phases of arm C, pembrolizumab will be administered on day 1 and enfortumab vedotin will be administered on days 1 and 8 of each cycle. Enrollment is complete for arm A ...

Trust Point Inc. trimmed its Amgen holdings by 40.5%, selling 897 shares and keeping 1,318 worth $411,000—because apparently, ...

We all have the power to shift our experience by shifting our attention. Training your focus on yourself, others, and the ...

Background Mobility limitation is prevalent in patients with heart failure (HF), but the dose-response relationship between ...

A first-in-class, brain-penetrant sGC stimulator, zagociguat is hypothesized to rebalance dysregulated cellular pathways in MELAS. By restoring cellular functions that support mitochondria, zagociguat ...

Boston Scientific’s Neuromodulation segment is charging ahead with a caffeinated jolt of momentum, posting 6.8% operational ...